|
| Saturday, September 24, 2022 |
|
|
Southern Score Honours Badminton World Champions, Aaron and Wooi Yik with RM100,000 Incentive |
| Southern Score Builders Berhad is pleased to present an incentive of RM100,000 to Malaysia's top men's doubles pair Aaron Chia and Soh Wooi Yik, who won Malaysia's first gold at the 2022 World Badminton Championships in Tokyo last month. more info >> |
|
| Friday, September 23, 2022 |
|
|
Malaysian Genomics Grows Presence in Thailand |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
| Wednesday, September 21, 2022 |
|
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
| Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
| Thursday, September 15, 2022 |
|
|
Sarawak Consolidated Industries Berhad Appoints Directors |
| Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) is pleased to announce the redesignation of Mr. Ku Chong Hong as Executive Director and the appointments of En. Mohd. Shakir bin Shahimi and En. Nuraiman Shaiful bin Annuar as Independent Non-Executive Directors (INED), effective today. more info >> |
|
|
Bintai Kinden Shareholders Approves All Resolutions at 28th AGM |
| Bintai Kinden Corporation Berhad (Bursa: BINTAI, 6998), a mechanical and electrical (M&E) engineering services specialist, is pleased to announce that shareholders have approved all resolutions at the 28th Annual General Meeting (AGM) of the Company held today on a virtual platform. more info >> |
|
| Tuesday, September 13, 2022 |
|
|
Shareholders of G Neptune Approved its Regularisation Plan |
| The non-interested shareholders of G Neptune Berhad have approved its proposed regularisation plan during the extraordinary general meeting (EGM) held today. The shareholders' approval marks a key milestone for G Neptune's proposed regularisation plan which is expected to address the Company's Guidance Note 3 (GN3) status as well as return it to a stronger financial standing as well as profitability. more info >> |
|
| Tuesday, September 6, 2022 |
|
|
Blackbixon Cafe Officially Debuts in Downtown KL |
| BlackBixon2Go Sdn. Bhd. (BB2GO), a subsidiary of Ni Hsin Group Berhad, is delighted to announce the official launch of the first BlackBixon Cafe & Restaurant today in a tastefully designed 3-storey bungalow house with a roof top garden. more info >> |
|
| Tuesday, August 30, 2022 |
|
|
Samaiden Group Posts 182% Jump in Full-Year Revenue |
| Samaiden Group Berhad, a renewable energy (RE) specialist principally involved in engineering, procurement, construction, and commissioning (EPCC) of solar photovoltaic (PV) systems and power plants today announced that for the fourth quarter ended 30 June 2022 (4Q FY2022), revenue increased 113.35% to RM53.68 million compared with RM25.16 million recorded in 4Q FY2021. more info >> |
|
|
PLS Plantations PAT up by 109.6% |
| PLS Plantations Berhad recorded a net profit after tax (PAT) of RM35.0 million, a strong conclusion to the financial year ended 30 June 2022 (FY2022). This represents an increase of 109.6% compared to RM16.7 million in the preceding financial year ended 30 June 2021 (FY2021). more info >> |
|
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
|
|
